RxDoctor Payments Data

Michael Tahery, MD

Gynecology · Glendale, CANPI 1346249539

Payments from drug & device makers

$344in general payments, 2019–2025

Across 5 payments — averaging $68.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$152
  • Amgen$122
  • Eisai Inc.$25
  • Biogen$23
  • Channel Medsystems, Inc.$22

What the payments were for

  • Food & beverage$344100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific1$152
Amgen1$122
Eisai Inc.1$25
Biogen1$23
Channel Medsystems, Inc.1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$344 in reported general payments places this provider in the 35th percentile of 247 gynecology providers in California.

See all gynecology providers in California

Medicare billing

Part B allowed, 2024
$320,079
Medicare patients
322
Services billed
7,614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron37$16,403
Estradiol18$1,655
Fesoterodine Fumarate ErFesoterodine Fumarate14$1,078
Oxybutynin Chloride ErOxybutynin Chloride51$776
Clobetasol Propionate18$689
Metronidazole13$488
Oxybutynin Chloride21$192
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst27$166
Nystatin12$79

Paid to pharmacies, not to this prescriber.

Other gynecology in Glendale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →